Soleil Raises Price Target on Monsanto from $145 to $160 (MON)
Get Alerts MON Hot Sheet
Price: $10.07 --0%
Rating Summary:
11 Buy, 13 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 13 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Soleil Securities Group raises its price target on Monsanto (NYSE: MON) from $145 to $160 and maintains a Buy rating.
The firm raised its FY08 EPS estimate from $3.05 to $3.40 after Monsanto boosted guidance about 17% yesterday (from $2.70-$2.80 to $3.15-$3.25), sending shares higher by 10%. In addition, Monsanto's stronger outlook caused other top players in the ag sector to rally: Mosaic (NYSE: MOS) jumped nearly 6%, Potash (NYSE: POT) rose about 4% and shares of Agrium (NYSE: AGU) moved about 5% higher.
Interestingly, Soleil said it believes "more research & development is the real story", referring to Monsanto's higher R&D spending moving into 2009. The firm said, "Given higher R&D spend to increase the present value of its long-duration R&D pipeline, our concern over multiple compression in ag names doesn't apply to Monsanto."
Soleil's $160 price target on Monsanto represents a 40% potential gain from yesterday's closing price of $114.54.
Monsanto Company, together with its subsidiaries, provides agricultural products for farmers principally in the United States. [BCS]
The firm raised its FY08 EPS estimate from $3.05 to $3.40 after Monsanto boosted guidance about 17% yesterday (from $2.70-$2.80 to $3.15-$3.25), sending shares higher by 10%. In addition, Monsanto's stronger outlook caused other top players in the ag sector to rally: Mosaic (NYSE: MOS) jumped nearly 6%, Potash (NYSE: POT) rose about 4% and shares of Agrium (NYSE: AGU) moved about 5% higher.
Interestingly, Soleil said it believes "more research & development is the real story", referring to Monsanto's higher R&D spending moving into 2009. The firm said, "Given higher R&D spend to increase the present value of its long-duration R&D pipeline, our concern over multiple compression in ag names doesn't apply to Monsanto."
Soleil's $160 price target on Monsanto represents a 40% potential gain from yesterday's closing price of $114.54.
Monsanto Company, together with its subsidiaries, provides agricultural products for farmers principally in the United States. [BCS]
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
- Wolverine World Wide (WWW) PT Raised to $31 at UBS on Growth, EPS Upside Potential
Create E-mail Alert Related Categories
Analyst Comments, Insiders' BlogRelated Entities
Soleil SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share